The DOI matches its Crossref record; 158 of the 159 references it cites were found in a registry or an index.
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
(1989) · PubMed · Cited by 3,343
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citation
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Items 701–800 of 1,008
Yang, Z. F., Poon, R. T. P., To, J. Y., Ho, D. W., & Fan, S. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3311 · Cited by 63
RetractedBioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N
McCarthy, H. O., Yakkundi, A., McErlane, V., et al. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700522 · Cited by 63
A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance
Yu, J., Kerbel, R. S., & Coomber, B. L. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700913.x · Cited by 65
Yoon, J., Le, X. T., Kim, J., Lee, H., Nguyen, N. T., Lee, W. T., Lee, E. S., Oh, K. T., Choi, H., & Youn, Y. S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.009 · Cited by 64
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 71
Chang, J., & Erler, J. T. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_3 · Cited by 67
Yamada, N., Yamanegi, K., Ohyama, H., Hata, M., Nakasho, K., Futani, H., Okamura, H., & Terada, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1630 · Cited by 62
Hypoxia-Inducible Factor in Thyroid Carcinoma
Burrows, N., Babur, M., Resch, J., Williams, K. J., & Brabant, G. E. (2011) · Journal of Thyroid Research · doi:10.4061/2011/762905 · Cited by 66
Ma, X., Zhang, H., Xue, X., & Shah, Y. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.805655 · Cited by 62
Greijer, A. E., de Jong, M. C., Scheffer, G. L., Shvarts, A., van Diest, P. J., & van der Wall, E. (2005) · Analytical Cellular Pathology · doi:10.1155/2005/236045 · Cited by 61
Dynamics of Hypoxia, Proliferation and Apoptosis after Irradiation in a Murine Tumor Model
Ljungkvist, A. S. E., Bussink, J., Kaanders, J. H. A. M., et al. (2006) · Radiation Research · doi:10.1667/rr3515.1 · Cited by 62
Temporal heterogeneity in oxygen tension in human melanoma xenografts
Brurberg, K. G., Graff, B. A., & Rofstad, E. K. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601047 · Cited by 62
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics
Zhu, D. Y., Zhu, X., Ren, S., Lu, Y., & Zhu, H. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1815209 · Cited by 61
Towards precision medicine using biochemically triggered cleavable conjugation
Parshad, B., Arora, S., Singh, B., Pan, Y., Tang, J., Hu, Z., & Patra, H. K. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01491-5 · Cited by 71
Using Optical Spectroscopy to Longitudinally Monitor Physiological Changes within Solid Tumors
Vishwanath, K., Yuan, H., Barry, W. T., et al. (2009) · Neoplasia · doi:10.1593/neo.09580 · Cited by 61
Mitsunaga, S., Hasebe, T., Iwasaki, M., et al. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00128.x · Cited by 61
Shin, S. J., Beech, J., & Kelly, K. A. (2012) · Integrative Biology · doi:10.1039/c2ib20047c · Cited by 61
Kim, Y. H., Shin, H. J., Jung, K., Baek, S., Shin, B. K., Choi, J. W., Kim, B., Shin, S. W., Kim, Y. H., Kim, J. S., et al. (2007) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hym121 · Cited by 61
Liu, F., Wang, P., Jiang, X. L., Tan, G., Qiao, H., Jiang, H., Krissansen, G. W., & Sun, X. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00905.x · Cited by 62
Baumann, R. P., Penketh, P. G., Seow, H. A., Shyam, K., & Sartorelli, A. C. (2008) · Radiation Research · doi:10.1667/rr1431.1 · Cited by 61
Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment
Elkashef, S. M., Allison, S. J., Sadiq, M., Basheer, H. A., Morais, G. R., Loadman, P. M., Pors, K., & Falconer, R. A. (2016) · Scientific Reports · doi:10.1038/srep33026 · Cited by 65
Kato, Y., Yashiro, M., Noda, S., Tendo, M., Kashiwagi, S., Doi, Y., Nishii, T., Matsuoka, J., Fuyuhiro, Y., Shinto, O., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605543 · Cited by 61
Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy
Kozal, K., Jóźwiak, P., & Krześlak, A. (2021) · Cancer Control · doi:10.1177/10732748211041243 · Cited by 65
Guo, X., Xue, H., Guo, X., Gao, X. C., Xu, S., Yan, S., Han, X., Li, T., Shen, J., & Li, G. (2015) · Oncotarget · doi:10.18632/oncotarget.5871 · Cited by 60
Development of hypoxia-sensitive Gd3+-based MRI contrast agents
Iwaki, S., Hanaoka, K., Piao, W., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.071 · Cited by 60
Moderate Hypoxia Induces β-Cell Dysfunction with HIF-1–Independent Gene Expression Changes
Sato, Y., Inoue, M., Yoshizawa, T., & Yamagata, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114868 · Cited by 60
Pathophysiology of Solid Tumors
Vaupel, P. W. (2009) · Medical radiology · doi:10.1007/978-3-540-74386-6_4 · Cited by 59
Self-citationThe Structure of Carbonic Anhydrase IX Is Adapted for Low-pH Catalysis
Mahon, B. P., Bhatt, A., Socorro, L., Driscoll, J. M., Okoh, C., Lomelino, C. L., Mboge, M. Y., Kurian, J. J., Tu, C., Agbandje‐McKenna, M., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00243 · Cited by 62
Meta-Alkoxy-Substituted Difluoroboron Dibenzoylmethane Complexes as Environment-Sensitive Materials
Daly, M. L., Kerr, C. P., DeRosa, C. A., & Fraser, C. L. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06910 · Cited by 61
Chaji, S., Al-Saleh, J., & Gomillion, C. T. (2020) · Gels · doi:10.3390/gels6010010 · Cited by 60
Correlation of Tumor Oxygen Dynamics with Radiation Response of the Dunning Prostate R3327-HI Tumor1
Zhao, D., Constantinescu, A., Chang, C.-H., et al. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0621:cotodw]2.0.co;2 · Cited by 60
Genetic Analysis of Hypoxia Signaling and Response in C. elegans
Shen, C., & Powell‐Coffman, J. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03222.x · Cited by 62
Fatima, H., Jin, Z. Y., Shao, Z., & Chen, X. J. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.04.087 · Cited by 60
Miyoshi, A., Kitajima, Y., Ide, T., Ohtaka, K., Nagasawa, H., Uto, Y., Hori, H., & Miyazaki, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.6.1533 · Cited by 59
Impact of preoperative anemia on relapse and survival in breast cancer patients
Zhang, Y., Chen, Y.-Y., Chen, D.-T., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-844 · Cited by 59
Intraductal carcinoma of the prostate: a critical re-appraisal
Varma, M., Delahunt, B., Egevad, L., et al. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02544-6 · Cited by 59
HIF-1α and p53: the ODD couple?
Fels, D. R., & Koumenis, C. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.06.009 · Cited by 63
Orally administered pimonidazole to label hypoxic tumor cells.
Bennewith, K. L., Raleigh, J. A., & Durand, R. E. (2002) · PubMed · Cited by 59
Bienia, A., Wiecheć-Cudak, O., Murzyn, A. A., & Krzykawska-Serda, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081147 · Cited by 60
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
Pei, Q., Jiang, B., Hao, D., & Xie, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.021 · Cited by 59
A review of the profile of endothelin axis in cancer and its management
Irani, S., Salajegheh, A., Smith, R. A., & Lam, A. K.-Y. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.08.011 · Cited by 60
Pietras, A., Johnsson, A. S., & Påhlman, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_72 · Cited by 62
Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials
Varu, V. N., Tsihlis, N. D., & Kibbe, M. R. (2008) · Vascular and Endovascular Surgery · doi:10.1177/1538574408322752 · Cited by 59
Leithner, K., Wohlkoenig, C., Stacher, E., Lindenmann, J., Hofmann, N., Gallé, B., Guelly, C., Quehenberger, F., Stiegler, P., Smolle‐Jüttner, F., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-40 · Cited by 58
Whom to blame for metastasis, the epithelial–mesenchymal transition or the tumor microenvironment?
Pietilä, M., Ivaska, J., & Mani, S. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.033 · Cited by 63
Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1α
Yoo, Y., Yeo, M. G., Kim, D. K., Park, H., & Lee, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408554200 · Cited by 58
Photoacoustic nanodroplets for oxygen enhanced photodynamic therapy of cancer
Xavierselvan, M., Cook, J. R., Duong, J., Diaz, N., Homan, K. A., & Mallidi, S. (2021) · Photoacoustics · doi:10.1016/j.pacs.2021.100306 · Cited by 58
Barve, K., Singh, U., Yadav, P. K., & Bhatia, D. D. (2023) · Materials Chemistry Frontiers · doi:10.1039/d2qm01287a · Cited by 57
Li, L., Huang, K., You, Y., Fu, X., Hu, L., Song, L., & Meng, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2368 · Cited by 59
Structural Insights into Carbonic Anhydrase IX Isoform Specificity of Carbohydrate-Based Sulfamates
Moeker, J., Mahon, B. P., Bornaghi, L. F., Vullo, D., Supuran, C. T., McKENNA, R. V., & Poulsen, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5012935 · Cited by 57
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer
Yun, S. J., Jo, S.-W., Ha, Y., et al. (2011) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.08.018 · Cited by 57
Hung, H., Klein, O. J., Peterson, S. W., et al. (2016) · Scientific Reports · doi:10.1038/srep33234 · Cited by 57
Meng, Q., Xu, J., Liang, C., Liu, J., Hua, J., Zhang, Y., Ni, Q., Shi, S., & Yu, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1244-z · Cited by 59
Fabrication of H 2 O 2 -driven nanoreactors for innovative cancer treatments
Dong, Z., Yang, Z., Hao, Y., & Feng, L. (2019) · Nanoscale · doi:10.1039/c9nr04418c · Cited by 56
Benjaminsen, I. C., Brurberg, K. G., Ruud, E. M., & Rofstad, E. K. (2007) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2007.06.003 · Cited by 57
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma
Cassim, S., Raymond, V., Lacoste, B., Lapierre, P., & Bilodeau, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25525 · Cited by 57
Carbon Ions for Hypoxic Tumors: Are We Making the Most of Them?
Sokol, O., & Durante, M. (2023) · Cancers · doi:10.3390/cancers15184494 · Cited by 58
Lutetium Texaphyrin–Celecoxib Conjugate as a Potential Immuno-Photodynamic Therapy Agent
An, J., Lv, K., Chau, C. V., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c05978 · Cited by 56
Molecular imaging of hypoxia in non-small-cell lung cancer
Yip, C., Blower, P. J., Goh, V., Landau, D., & Cook, G. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3009-6 · Cited by 56
Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells
Mengelbier, L. H., Jögi, A., & Påhlman, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21024 · Cited by 56
RRx-001, A novel dinitroazetidine radiosensitizer
Oronsky, B. T., Scicinski, J. J., Ning, S., et al. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0326-y · Cited by 56
Wang, R.-X., Liu, H., Xu, L., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4729 · Cited by 56
H2O2-responsive theranostic nanomedicine
Yu, L., Chen, Y., & Chen, H. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.05.023 · Cited by 57
Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer
Asghari, M. H., Moloudizargari, M., Ghobadi, E., Fallah, M., & Abdollahi, M. R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.020 · Cited by 58
Photoacoustic Imaging in Oxygen Detection
Cao, F., Qiu, Z., Li, H., & Lai, P. (2017) · Applied Sciences · doi:10.3390/app7121262 · Cited by 56
Cochran, J. M., Busch, D. R., Leproux, A., Zhang, Z., O’Sullivan, T. D., Cerussi, A. E., Carpenter, P. M., Mehta, R. S., Roblyer, D. M., Yang, W. T., et al. (2018) · Journal of Biomedical Optics · doi:10.1117/1.jbo.24.2.021202 · Cited by 56
Karwicka, M., Pucelik, B., Gonet, M., Elas, M., & Dąbrowski, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49064-6 · Cited by 56
Measurement of Hypoxia-related Parameters in Bronchial Mucosa by Use of Optical Spectroscopy
Bard, M. P. L., Amelink, A., Hegt, V. N., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-046oc · Cited by 56
Aft, R., Lewis, J. S., Zhang, F., Kim, J., & Welch, M. J. (2003) · PubMed · Cited by 56
Hwang, J.-T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh253 · Cited by 56
Kunkel, M., Förster, G. J., Reichert, T. E., et al. (2002) · Oral Oncology · doi:10.1016/s1368-8375(02)00087-8 · Cited by 56
Zang, Y., Wang, Y., Zhang, J., Xia, M., Jiang, Z., Jia, B., Lu, C., Chen, C., Wang, S., Zhang, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110188 · Cited by 67
Onozuka, H., Tsuchihara, K., & Esumi, H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01880.x · Cited by 55
Lalani, A. S., Alters, S. E., Wong, A., Albertella, M. R., Cleland, J. L., & Henner, W. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2427 · Cited by 55
Necrotic core in EMT6/Ro tumour spheroids: Is it caused by an ATP deficit?
BERTUZZI, A., Fasano, A., Gandolfi, A., & Sinisgalli, C. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.09.024 · Cited by 54
Vāvere, A. L., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.11.012 · Cited by 55
Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy
Yotnda, P., Wu, D., & Swanson, A. M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_1 · Cited by 59
Guo, X., Xu, S., Gao, X. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18673 · Cited by 55
Kang, Y. B., Eo, J., Bulutoglu, B., Yarmush, M. L., & Usta, O. B. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27225 · Cited by 55
Cho, W.-K., Seong, Y. R., Lee, Y. H., Kim, M. J., Hwang, K., Yoo, J., Choi, S., Jung, C., & Im, D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.023 · Cited by 57
Design of Hypoxia-Targeting Drugs as New Cancer Chemotherapeutics
Nagasawa, H., Uto, Y., Kirk, K. L., & Hori, H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.2335 · Cited by 55
Papadopoulos, K. P., Goel, S., Beeram, M., Wong, A., Desai, K. K., Haigentz, M., Milián, M. L., Mani, S., Tolcher, A. W., Lalani, A. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0483 · Cited by 55
Heylman, C., Sobrino, A., Shirure, V. S., Hughes, C. C., & George, S. C. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214525295 · Cited by 53
“As a result, the microenvironment remains acidic, adversely affecting the action of many chemotherapeutic drugs as reviewed elsewhere.(41,42) Hypoxia also promotes epithelial-to-mesenchymal transition, which is marked by increased motility of cancer cells and results into invasion of surrounding tissue.”
BackgroundRoy, V., Magne, B., Vaillancourt-Audet, M., Blais, M., Chabaud, S., Grammond, E., Piquet, L., Fradette, J., Laverdière, I., Moulin, V. J., et al. (2020) · BioMed Research International · doi:10.1155/2020/6051210 · Cited by 57
Assidicky, R., Tokat, Ü. M., Tarman, I. O., Saatci, Ö., Ersan, P. G., Raza, U., Oğul, H., Riazalhosseini, Y., Can, T., & Şahin, Ö. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06569-5 · Cited by 55
Steinkamp, M. P., Winner, K. K., Davies, S., Muller, C. Y., Zhang, Y., Hoffman, R. M., Shirinifard, A., Moses, M. E., Jiang, Y., & Wilson, B. S. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00097 · Cited by 54
Xia, J., Danielli, A., Liu, Y., Wang, L., Maslov, K., & Wang, L. V. (2013) · Optics Letters · doi:10.1364/ol.38.002800 · Cited by 54
Cobalt complexes with tripodal ligands: implications for the design of drug chaperones
Bonnitcha, P., Kim, B. J., Hocking, R. K., Clegg, J. K., TURNER, P. R., Neville, S. M., & Hambley, T. W. (2012) · Dalton Transactions · doi:10.1039/c2dt30727h · Cited by 55
Hsieh, C., Lin, Y., Wu, C., Lee, H., Shyu, W., & Wang, C.-C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0618 · Cited by 54
Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma
Qin, Y. W., Roszik, J., Chattopadhyay, C., Hashimoto, Y., Liu, C., Cooper, Z. A., Wargo, J. A., Hwu, P., Ekmekçioglu, S., & Grimm, E. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0963 · Cited by 54
Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden
Bohn, K. A., Adkins, C. E., Nounou, M. I., & Lockman, P. R. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00193 · Cited by 54
Aumayr, K., Fathi, O., Traub‐Weidinger, T., Niederle, B., & Koperek, O. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0232-4 · Cited by 54
Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance
Kurebayashi, J. (2003) · Breast Cancer · doi:10.1007/bf02967635 · Cited by 54
The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT
Moon, E. J., Petersson, K., & Olcina, M. M. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1988178 · Cited by 59
Engineering Human Tumor-specific Cytotoxic T Cells to Function in a Hypoxic Environment
Kim, H.-S., Peng, G., Hicks, J. M., Weiss, H. L., Meir, E. G. V., Brenner, M. K., & Yotnda, P. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300391 · Cited by 53
Ueda, J., Ho, J. C., Lee, K. L., Kitajima, S., Yang, H. H., Sun, W., Fukuhara, N., Zaiden, N., Chan, S. L., Tachibana, M., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00099-14 · Cited by 54
Peng, W., Xiong, E., Ge, L., Wan, Y.-Y., Zhang, C., Du, F., Xu, M., Bhat, R. A., Jin, J., & Gong, A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.12.006 · Cited by 53
The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
Movahedi, K., & Ginderachter, J. A. V. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6704 · Cited by 53
Marine anticancer drugs and their relevant targets: a treasure from the ocean
Nigam, M., Suleria, H. A. R., Farzaei, M. H., & Mishra, A. P. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00273-4 · Cited by 53
Karges, J., Kuang, S., Ong, Y. C., Chao, H., & Gasser, G. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202003486 · Cited by 53
Metadata
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review